Worldwide Clinical Trials Drug Development Solutions is Drug Discovery in United States that focus on specialized studies business. Founded in 1990. They cover business area such as provider, clinical research service, specialized study, drug dose, formulation, regimen, interaction, genotype, gender, pharmacokinetic.
1990
( 34 years old in 2024 )
Specialized Studies
-
8605 Cross Park Drive
Austin, TX 78754
United States
Private
providerclinical research servicespecialized studydrug doseformulationregimeninteractiongenotypegenderpharmacokinetic
* We use standard office opening hours in near Worldwide Clinical Trials Drug Development Solutions's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Worldwide Clinical Trials Drug Development Solutions is Drug Discovery business from United States that founded in 1990 (34 years old in 2024), Worldwide Clinical Trials Drug Development Solutions business is focusing on Specialized Studies.
Worldwide Clinical Trials Drug Development Solutions headquarter office and corporate office address is located in 8605 Cross Park Drive Austin, TX 78754 United States.
Worldwide Clinical Trials Drug Development Solutions was founded in United States.
In 2024, Worldwide Clinical Trials Drug Development Solutions is currently focus on specialized studies sector.
Above is snippet of Google Trends for "specialized studies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Worldwide Clinical Trials Drug Development Solutions, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.